4-FMA

Controlled under the Neue-Psychoaktive-Substanzen-Gesetz (New Psychoactive Substances Act).² Possession, production, and sale are prohibited.

Controlled since 1996 as an analogue of methamphetamine.³ Falls under the Controlled Drugs and Substances Act with associated criminal penalties for possession, trafficking, and production.

Government Decree 651/2026 is the latest schedule amendment as of 2026-08-28 and states that it enters into force on 10 July 2026; its Annex IV retains the exact 4-FMA entry. Annex IV also covers chemically possible stereoisomers (unless specifically excluded), salts where salt formation is possible, and preparations containing listed substances. Finland's Narcotics Act § 3 defines a narcotic by reference to the 1961/1971 convention lists and other specified categories, with the Government decree supplying the detailed substance lists; § 5 prohibits unauthorized production, manufacture, import, export, transport, distribution, trade, handling, possession and use. Criminal Code Chapter 50 § 1 provides a fine or imprisonment up to two years for an ordinary narcotics offence, including possession or attempted acquisition and distribution; § 2 provides imprisonment of one to ten years for an aggravated offence when statutory aggravating conditions and overall seriousness are met; § 2a provides a fine or up to six months for illegal use or possession/acquisition of a small amount for personal use. These are statutory ranges, not a prediction of sentence in a particular case.

Listed as a Schedule I controlled substance under Italian drug legislation.¹⁶ Production, sale, and possession are prohibited.

The current MHLW list identifies 4-FMA as a designated drug, and MHLW expressly states that designated-drug possession and use, as well as purchase and receipt, have been prohibited since 1 April 2014. Ordinary possession and use are therefore prohibited, with no personal-possession exemption; any legally authorized statutory or medical context must be assessed separately under the applicable PMD Act provisions.

Controlled under the Misuse of Drugs Act 1971, added through the 1977 amendment covering fluorinated amphetamine derivatives.²³ Class A designation carries the most severe penalties including up to 7 years imprisonment for possession.

Prohibited substance under the Poisons Standard.¹ This category applies to substances with abuse or misuse potential; manufacture, possession, sale, and use are meant to be legally barred except for health-authority-approved medical or scientific research, analysis, teaching, or training.

Designated a controlled substance as of October 2015 under national drug control legislation.⁴

Controlled under Schedule II of the Betäubungsmittelgesetz (Narcotics Act) since July 26, 2012.¹⁵ Manufacturing, possession, import, export, purchase, sale, procurement, and dispensing without license are prohibited.

Controlled as an amphetamine analogue under the Misuse of Drugs Act.¹⁹ Schedule 3 substances carry penalties for possession, supply, and manufacture.

The exact substance is expressly named as item 16 in the current consolidated BetmVV-EDI Annex 6 Verzeichnis e. That category is controlled under BetmVV-EDI Articles 1(2)(a) and 2(2), with the Article 7 BetmG authorization framework and EDI permit requirement described by BetmKV. Verzeichnis e is distinct from Verzeichnis d and controls 4-FMA through authorization rather than categorically prohibiting every act involving it.

Not specifically scheduled at the federal level. However, as a structural analogue of methamphetamine, sale or possession could be prosecuted under the Federal Analogue Act when intended for human consumption.²⁴

The ANSM narcotics list dated 26 June 2026 comprises 58 pages and contains entries for 4-fluoroamphétamine/4-FA and for Méthamphétamine et son racémate, but no 4-FMA, 4-fluorométhamphétamine, fluoromethamphetamine or CAS 351-03-1 entry. Its scope clauses cover the named substances and specified isomers, esters, ethers, salts and preparations; 4-FMA is a para-fluoro N-methyl derivative, not an isomer of methamphetamine, and the list contains no general amphetamine-analogue clause that would itself capture it. The ANSM psychotropics list dated 3 July 2026 likewise contains no 4-FMA or 4-fluoromethamphetamine entry. MILDECA's December 2025 government guide explains that some new synthetic substances are not yet classified as narcotics and consequently escape narcotics legislation while awaiting identification/classification. Under the narcotics/psychotropics schedules, 4-FMA is unscheduled; this is not an affirmative declaration that every possession, import, sale or preparation is lawful under every French regime. Service-Public.fr states that use of substances classified as narcotics carries a 500 EUR fixed fine (400 EUR reduced, 1,000 EUR increased) and, in court, up to one year imprisonment and 3,750 EUR fine. Because 4-FMA is absent from the current schedules, those narcotics-use penalties do not apply to it solely by analogy; other rules (for example medicines, customs, product-safety or a later ANSM classification) are outside this schedule-based classification.